Biotech Target N V - Jul 26, 2021 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Stock symbol: MTEM
Transactions as of: Jul 26, 2021
Transactions value $: $1,091,656
Form type: 4
Date filed: 7/28/2021, 12:23 PM
Previous filing: Jul 21, 2021
Next filing: Sep 20, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTEM	Common Stock	Purchase	$560K	+80K	+0.82%	$7.00^*	9.87M	Jul 26, 2021	Direct
transaction	MTEM	Common Stock	Purchase	$532K	+75K	+0.76%	$7.09^*	9.94M	Jul 27, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.